However, plasma levels of ALT and AST can be difficult to interpret as these markers can be elevated in models of general liver dysfunction, thus readouts can be confounded by improvements in liver function due to ASO-mediated actions, as seen with ASOs targeting Stk25 (Cansby et al., 2019). The gene discussed is GPT; the disease is Decreased liver function.